Breast carcinoma is the most prevalent category of malignancy in women globally. As breast cancer survivors and rescuers report a variety of health conditions which somehow impair their standard of living, the advancement of breast cancer treatment effective interventions while minimizing the potential negative consequences would be obligated. Precision medicine in oncology aims to tailor almost every patient's rehabilitation regimen depending on it as an accurate assessment and management of tumor recurrence and maybe even advancement. Precision will always be successfully accomplished throughout every stage of medical services, from target identification to diagnostic testing to surgical intervention, interventional procedures, and radiotherapy, and finally high mortality or even supplementation actually give a damn. Precision results from intimate analysis from each tumor's underlying biological proclivities, that instead of generalizing treatment programs predicated upon phenotypes or perhaps genetic variability categorization. Ongoing clinical strategy is evolving to accommodate the new perspectives, such as drifting away from categorizing large and diverse treatment methods into additional therapeutic comparability groups. The whole investigation encompasses several fields of clinical research investment. That very same special issue focuses on the analysis work of several parties concerned in precision medicine for breast cancer